IL13 and chronic rhinosinusitis with nasal polyps: Type 2 (T2) inflammation, featuring eosinophilia and elevated levels of interleukin (IL)-5 and IL-13, is a common component of CRSwNP and is present in approximately 69%–90% of patients from Western countries [9–11].